149 related articles for article (PubMed ID: 12759578)
21. [IgA nephropathy].
Alamartine E
Rev Prat; 2003 Nov; 53(18):2023-6. PubMed ID: 15008216
[TBL] [Abstract][Full Text] [Related]
22. Effect of corticosteroid therapy on the progression of IgA nephropathy with moderate proteinuria.
Uzu T; Harada T; Ko M; Yamato M; Takahara K; Yamauchi A
Clin Exp Nephrol; 2003 Sep; 7(3):210-4. PubMed ID: 14586717
[TBL] [Abstract][Full Text] [Related]
23. Corticosteroid therapy in IgA nephropathy.
Lv J; Xu D; Perkovic V; Ma X; Johnson DW; Woodward M; Levin A; Zhang H; Wang H;
J Am Soc Nephrol; 2012 Jun; 23(6):1108-16. PubMed ID: 22539830
[TBL] [Abstract][Full Text] [Related]
24. [IgA nephropathy (immunoglobulin A nephropathy, M.Berger). Main symptoms: (painless) macrohematuria or microhematuria].
Kolyvanos Naumann U; Käser L; Vetter W
Praxis (Bern 1994); 2004 Oct; 93(44):1809-13; quiz 1814. PubMed ID: 15559904
[No Abstract] [Full Text] [Related]
25. [IgA nephropathy--the most common form of glomerulonephritis].
Pettersson E
Duodecim; 1995; 111(15):1435-41. PubMed ID: 9244699
[No Abstract] [Full Text] [Related]
26. Corticosteroid therapy in patients with IgA nephropathy and impaired renal function.
Tamura S; Ueki K; Ideura H; Tsukada Y; Maezawa A; Kawai H; Wakamatsu R; Yano S; Nojima Y; Naruse T
Clin Nephrol; 2001 Mar; 55(3):192-5. PubMed ID: 11316238
[TBL] [Abstract][Full Text] [Related]
27. Immunosuppression in IgA nephropathy: how certain are we?
Floege J; Rauen T
Kidney Int; 2016 Jan; 89(1):9-11. PubMed ID: 26759037
[TBL] [Abstract][Full Text] [Related]
28. IgA nephropathy: challenges and opportunities.
Glassock RJ
Cleve Clin J Med; 2008 Aug; 75(8):569-76. PubMed ID: 18756838
[TBL] [Abstract][Full Text] [Related]
29. Predictors for progression in immunoglobulin A nephropathy with significant proteinuria.
Hwang HS; Kim BS; Shin YS; Yoon HE; Song JC; Choi BS; Park CW; Yang CW; Kim YS; Bang BK
Nephrology (Carlton); 2010 Mar; 15(2):236-41. PubMed ID: 20470285
[TBL] [Abstract][Full Text] [Related]
30. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
Moriyama T; Honda K; Nitta K; Yumura W; Nihei H
Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
[TBL] [Abstract][Full Text] [Related]
31. Treatment of primary IgA nephropathy.
Alexopoulos E
Kidney Int; 2004 Jan; 65(1):341-55. PubMed ID: 14675076
[No Abstract] [Full Text] [Related]
32. Primary IgA nephropathy: natural history and factors of importance in the progression of renal impairment.
Ibels LS; Gyory AZ; Caterson RJ; Pollock CA; Mahony JF; Waugh DA; Roger SD; Coulshed S
Kidney Int Suppl; 1997 Oct; 61():S67-70. PubMed ID: 9328970
[No Abstract] [Full Text] [Related]
33. Rituximab for recurrent IgA nephropathy in kidney transplantation: A report of three cases and proposed mechanisms.
Chancharoenthana W; Townamchai N; Leelahavanichkul A; Wattanatorn S; Kanjanabuch T; Avihingsanon Y; Praditpornsilpa K; Eiam-Ong S
Nephrology (Carlton); 2017 Jan; 22(1):65-71. PubMed ID: 26758857
[TBL] [Abstract][Full Text] [Related]
34. [Surprising increase of creatinine].
Schobel HP
MMW Fortschr Med; 2013 Dec; 155(21-22):48-9. PubMed ID: 24724274
[No Abstract] [Full Text] [Related]
35. Can immunosuppressive therapy be useful in IgA nephropathy when the 'Point of No Return' has already been exceeded?
Pozzi C; Del Vecchio L; Locatelli F
Nephron; 2002; 92(3):699-701. PubMed ID: 12372958
[TBL] [Abstract][Full Text] [Related]
36. IgA Nephritis with Declining Renal Function: Treatment with Corticosteroids May Be Worthwhile.
Ponticelli C; Glassock RJ
J Am Soc Nephrol; 2015 Sep; 26(9):2071-3. PubMed ID: 25677390
[No Abstract] [Full Text] [Related]
37. [Immunoglobulin A nephropathy].
Seikrit C; Rauen T; Floege J
Internist (Berl); 2019 May; 60(5):432-439. PubMed ID: 30895344
[TBL] [Abstract][Full Text] [Related]
38. Can immunosuppressive drugs slow the progression of IgA nephropathy?
Goumenos D; Ahuja M; Shortland JR; Brown CB
Nephrol Dial Transplant; 1995; 10(7):1173-81. PubMed ID: 7478120
[TBL] [Abstract][Full Text] [Related]
39. Supportive Versus Immunosuppressive Therapy of Progressive IgA nephropathy (STOP) IgAN trial: rationale and study protocol.
Eitner F; Ackermann D; Hilgers RD; Floege J
J Nephrol; 2008; 21(3):284-9. PubMed ID: 18587715
[TBL] [Abstract][Full Text] [Related]
40. Baseline proteinuria, urinary osmotic pressure, and renal function as positive predictors of corticosteroids plus cyclophosphamide treatment efficacy in IgA nephropathy.
Fang J; Li W; Li D; Tan Z
Chin Med J (Engl); 2014; 127(9):1710-4. PubMed ID: 24791879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
